Trade Mark Journal No.2025/042 17 October 2025

WO0000001879394 (5)

Office of origin: United States of America

Date of International Registration:10 September 2025
Date of designation in the UK: 10 September 2025
Image for mark 1879394 ENLANPPI

International priority date claimed: 10 March 2025 (United States of America) (99075149)
Class 5
Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of bone diseases and disorders; pharmaceutical preparations and substances for the treatment of pathological calcification; pharmaceutical preparations and substances for the treatment of blood plasma pyrophosphate deficiency disorders; pharmaceutical preparations and substances for the treatment of kidney diseases and disorders.

Inozyme Pharma, Inc.

Representative: Gregory J. Chinlund Marshall Gerstein & Borun LLP, 233 S. Wacker Drive, 6300 Willis Tower, Chicago IL 60606, UNITED STATES OF AMERICA